Cargando…
2067. Preclinical Characterization of Rationally Designed Microbial Consortia to Prevent Bacterial Infections in Patients with Chronic Liver Disease
BACKGROUND: In chronic liver disease (CLD), gut microbiome disruption worsens with disease severity and growing evidence suggests it is a key driver of infection risk through a combination of intestinal pathogen expansion from a loss of colonization resistance and dysfunction of the gastrointestinal...
Autores principales: | Halvorsen, Elizabeth, Vulić, Marin, Barrasso, Kelsey, Beauchemin, Nicholas, Brown, Jessica, Ennis, Nathaniel J, Mayol, Melissa, Wurster, Jenna, O’Brien, Edward J, Ford, Christopher, Henn, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678321/ http://dx.doi.org/10.1093/ofid/ofad500.137 |
Ejemplares similares
-
2156. The Rational Design of SER-147: a Cultivated Microbial Consortium to Restore Colonization Resistance and Mitigate Infection in Chronic Liver Disease
por: Wurster, Jenna, et al.
Publicado: (2023) -
130. Design and Preclinical Characterization of SER-155, an Investigational Cultivated Microbiome Therapeutic to Restore Colonization Resistance and Prevent Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Halvorsen, Elizabeth, et al.
Publicado: (2021) -
COLLABORATION AGREEMENT KE2067/GS
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2012) -
Clocks Generation PS/RF-LL 2067/2
por: Blas, F, et al.
Publicado: (1995) -
Clocks Generation PS/RF-LL 2067/2
por: Blas, F, et al.
Publicado: (1995)